Jun-Ting Cheng

1.1k citations
15 papers · 885 · 1 hit paper · h-index 11

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Immunology top 10%
    • Immunotherapy and Immune Responses

Papers in

    • RNA modifications and cancer 3
    • RNA Interference and Gene Delivery 1
    • Virus-based gene therapy research 5

Jun-Ting Cheng

14 papers receiving 867 citations

Jun-Ting Cheng's Hit Papers

Dendritic cell biology and its role in tumor immunotherapy 2020 · 342 citations
3420+2+4Years since publication100200300

Peers

Jun-Ting Cheng
Comparison fields: 5 of 82
  • Cancer Research 197
  • Immunology 263
  • Oncology 321
  • Molecular Biology 412
  • Radiology, Nuclear Medicine and Imaging 82
Replace Lopamudra Das Roy with:
Lopamudra Das Roy United States
Н. В. Литвяков Russia
Valesca Boisguérin Germany
Isabelle Matte Canada
Rebecca J. Boohaker United States
Anna Rossini Italy
Thomas Bukur Germany
Euphemia W. Mu United States
Saroj K. Basak United States
Paul M. Grandgenett United States
Jun-Ting Cheng relative to Lopamudra Das Roy United States Lopamudra Das Roy's profile →
Citations per field
00.5×1.5×2.1×
Lopamudra Das Roy · 1×
Citations per year

Countries citing papers authored by Jun-Ting Cheng

Since Specialization
Citations

This map shows the geographic impact of Jun-Ting Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Ting Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Ting Cheng more than expected).

Fields of papers citing papers by Jun-Ting Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-Ting Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Ting Cheng. The network helps show where Jun-Ting Cheng may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun-Ting Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun-Ting Cheng Line = papers co-authored together Jun-Ting Cheng links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Dendritic cell biology and its role in tumor immunotherapy
Hit paper breakdown →
2020342
2 2019157
3 2020136
4 202079
5 202142
6 202032
7
Bispecific T cell engagers and their synergistic tumor immunotherapy with oncolytic viruses.
202124
8 201824
9 201915
10 202011
11 200510
12 20206
13 20205
14 20211
15 20211

About Jun-Ting Cheng

Jun-Ting Cheng is a scholar working on Molecular Biology, Genetics, Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 885 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Herpesvirus Infections and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), RNA modifications and cancer (3 papers), CAR-T cell therapy research (2 papers), Vector-Borne Animal Diseases (1 paper), RNA Interference and Gene Delivery (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Cancer Research (197 citations), Immunology (263 citations), Oncology (321 citations), Molecular Biology (412 citations) and Radiology, Nuclear Medicine and Imaging (82 citations). Jun-Ting Cheng has collaborated with scholars based in China, Singapore and Germany. Frequent co-authors include Zhaowu Ma, Hong-Wu Xin, Yingying Wang, Ying Xiang, Xianwang Wang, Xiaochun Peng, Shuzhong Cui, Wen-Qi Cai, Lingzhi Wang and Gautam Sethi. Their work appears in journals such as Journal of Cancer, Frontiers in Oncology, Frontiers in Pharmacology, Drug Delivery and Journal of Hematology & Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact